Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
An update from Hookipa Pharma ( (HOOK) ) is now available.
HOOKIPA Pharma Inc. filed a petition in the Delaware Court of Chancery on December 27, 2024, to validate actions taken during its 2022 and 2023 Annual Stockholder Meetings. These actions include the approval of director elections and amendments to the company’s certificate of incorporation and stock option plan. The company is seeking validation due to incorrect record dates set for these meetings, which contravened the Delaware General Corporation Law. The Court of Chancery has approved an expedited proceeding, with a final hearing scheduled for February 14, 2025, where stockholders can express their positions.
More about Hookipa Pharma
YTD Price Performance: 0.51%
Average Trading Volume: 133,158
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $19.39M
See more insights into HOOK stock on TipRanks’ Stock Analysis page.
